Matulonis, U: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies

U Matulonis, S Campos, L Duska, A Fuller, R Berkowitz, S Gore, M Roche, T Colella, H Lee, M.V Seiden

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 155 KB

english, 2003

52

End of life issues in older patients

Ursula A Matulonis

Journal:

Seminars in Oncology

Year:

2004

Language:

english

File:

PDF, 93 KB

english, 2004

53

Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival

Joyce Liu, Mihaela C. Cristea, Paul Frankel, Susan L. Neuhausen, Linda Steele, Verena Engelstaedter, Ursula Matulonis, Sharon Sand, Nadine Tung, Judy E. Garber, Jeffrey N. Weitzel

Journal:

Cancer Genetics

Year:

2012

Language:

english

File:

PDF, 301 KB

english, 2012

54

Cytokines IL-1b, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFa in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel

R.T. Penson, K. Kronish, Z. Duan, A. Feller, P. Stark, S.E. Cook, L.R. Duska, A.F. Fuller, A.K. Goodman, N. Nikrui, K.M. MacNeill, U.A. Matulonis, F.I. Preffer, M.V. Seiden

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 169 KB

english, 1999

55

Phase II trial of anastrozole in women with asymptomatic müllerian cancer

Marcela G.del Carmen, Arlan F Fuller, Ursula Matulonis, Nora K Horick, Annekathryn Goodman, Linda R Duska, Richard Penson, Susana Campos, Maria Roche, Michael V Seiden

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 181 KB

english, 2003

56

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

N.S. Horowitz, A.B. Olawaiye, D.R. Borger, W.B. Growdon, C.N. Krasner, U.A. Matulonis, J.F. Liu, J. Lee, L. Brard, D.S. Dizon

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 488 KB

english, 2012

57

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

Ursula A. Matulonis, Sudarshan Sharma, Sharad Ghamande, Michael S. Gordon, Salvatore A. Del Prete, Isabelle Ray-Coquard, Elzbieta Kutarska, Hua Liu, Howard Fingert, Xiaofei Zhou, Hadi Danaee, Russell

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 408 KB

english, 2012

58

170 A6, a urokinase plasminogen activator (uPA)-derived peptide: a phase I trial in patients with advanced gynecologic cancer

A. Berkenblit, M.A. Gold, U.A. Matulonis, J.F. Kroener, B.J. Dezube, G.N. Lam, N. Brünner, T.R. Jones, M.H. Silverman

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 151 KB

english, 2004

59

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

Ursula A. Matulonis, Julie Lee, Brian Lasonde, William P. Tew, Afra Yehwalashet, Daniela Matei, Kian Behbakht, Jill Grothusen, Gini Fleming, Nita K. Lee, Jamie Arnott, Mark R. Bray, Graham Fletcher, R

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 757 KB

english, 2013

60

Successful desensitization to paclitaxel (Taxol®) in ten patients using a standardized protocol

Feldweg, A., Price, K., Matulonis, U., Castells, M.

Journal:

Journal of Allergy and Clinical Immunology

Year:

2003

Language:

english

File:

PDF, 125 KB

english, 2003

61

35 Mutational analysis of epithelial ovarian cancer using OncoMap

U. Matulonis, M. Hirsch, J. Liu, W. Hahn

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

62

569 Whole-genome sequencing and analysis of an ovarian cancer patient

S. Bentink, R. Sultana, R. Rubio, U. Matulonis, J. Quackenbush

Journal:

European Journal of Cancer Supplements

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

63

Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy

Chonghaile, T. N., Sarosiek, K. A., Vo, T.-T., Ryan, J. A., Tammareddi, A., Moore, V. D. G., Deng, J., Anderson, K. C., Richardson, P., Tai, Y.-T., Mitsiades, C. S., Matulonis, U. A., Drapkin, R., Sto

Journal:

Year:

2011

Language:

english

File:

PDF, 300 KB

english, 2011

64

Predators, alternative prey and climate influence annual breeding success of a long-lived sea duck

Iles, David T., Rockwell, Robert F., Matulonis, Paul, Robertson, Gregory J., Abraham, Kenneth F., Davies, J. Chris, Koons, David. N., Smallegange, Isabel

Journal:

Journal of Animal Ecology

Year:

2013

Language:

english

File:

PDF, 1.38 MB

english, 2013

65

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer

Liu, Joyce F., Tolaney, Sara M., Birrer, Michael, Fleming, Gini F., Buss, Mary K., Dahlberg, Suzanne E., Lee, Hang, Whalen, Christin, Tyburski, Karin, Winer, Eric, Ivy, Percy, Matulonis, Ursula A.

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 580 KB

english, 2013

66

New Biologic Agents for the Treatment of Gynecologic Cancers

Horowitz, Neil, Matulonis, Ursula A.

Journal:

Hematology/Oncology Clinics of North America

Year:

2012

Language:

english

File:

PDF, 165 KB

english, 2012

67

Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer

Townamchai, Kanokpis, Berkowitz, Ross, Bhagwat, Mandar, Damato, Antonio L., Friesen, Scott, Lee, Larissa J., Matulonis, Ursula, O'Farrell, Desmond, Viswanathan, Akila N.

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 227 KB

english, 2013

68

A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab (Bev) Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer: One-Year Results from RTOG 0921

Viswanathan, A.N., Moughan, J., Miller, B.E., Xiao, Y., Matulonis, U.A., Horowitz, N.S., Mannel, R.S., Souhami, L., Erickson, B., Gaffney, D.K.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2013

Language:

english

File:

PDF, 63 KB

english, 2013

69

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients

Liu, Joyce F., Kindelberger, David, Doyle, Courtney, Lowe, Alarice, Barry, William T., Matulonis, Ursula A.

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 447 KB

english, 2013

70

A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma

Campos, Susana M., Penson, Richard T., Matulonis, Ursula, Horowitz, Neil S., Whalen, Christin, Pereira, Lauren, Tyburski, Karin, Roche, Maria, Szymonifka, Jackie, Berlin, Suzanne

Journal:

Gynecologic Oncology

Year:

2013

Language:

english

File:

PDF, 222 KB

english, 2013

71

A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer

Viswanathan, Akila N., Lee, Hang, Berkowitz, Ross, Berlin, Suzanne, Campos, Susanna, Feltmate, Colleen, Horowitz, Neil, Muto, Michael, Sadow, Cheryl A., Matulonis, Ursula

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 212 KB

english, 2014

72

Overexpression of Elafin in Ovarian Carcinoma Is Driven by Genomic Gains and Activation of the Nuclear Factor κB Pathway and Is Associated with Poor Overall Survival

Clauss, Adam, Ng, Vivian, Liu, Joyce, Piao, Huiying, Russo, Moises, Vena, Natalie, Sheng, Qing, Hirsch, Michelle S., Bonome, Tomas, Matulonis, Ursula, Ligon, Azra H., Birrer, Michael J., Drapkin, Ronn

Journal:

Year:

2010

Language:

english

File:

PDF, 2.09 MB

english, 2010

73

PARP inhibitors in ovarian cancer: Current status and future promise

Liu, Joyce F., Konstantinopoulos, Panagiotis A., Matulonis, Ursula A.

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 318 KB

english, 2014

74

Octréotide à action prolongée dans le traitement de l’occlusion intestinale symptomatique chez des patientes porteur d’un cancer ovarien évolué

Matulonis, U.-A., Seiden, M., Roche, M.

Journal:

Médecine Palliative : Soins de Support - Accompagnement - Éthique

Year:

2006

Language:

french

File:

PDF, 89 KB

french, 2006

75

Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen

Lee, Larissa J., DeMaria, Rebecca, Berkowitz, Ross, Matulonis, Ursula, Viswanathan, Akila N.

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 249 KB

english, 2014

76

5002 ORAL Results from a Phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer

Makhija, S., Glenn, D., Ueland, F., Dizon, D., Paton, V., Lin, C.Y., Amler, L., Sliwkowski, M., Strauss, A., Matulonis, U.

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 77 KB

english, 2007

77

Acupuncture as Palliative Therapy for Physical Symptoms and Quality of Life for Advanced Cancer Patients

Dean-Clower, E., Doherty-Gilman, A. M., Keshaviah, A., Baker, F., Kaw, C., Weidong Lu,, Manola, J., Penson, R. T., Matulonis, U. A., Rosenthal, D. S.

Journal:

Integrative Cancer Therapies

Year:

2010

Language:

english

File:

PDF, 373 KB

english, 2010

78

Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status

Gordon, M. S., Matei, D., Aghajanian, C., Matulonis, U. A., Brewer, M., Fleming, G. F., Hainsworth, J. D., Garcia, A. A., Pegram, M. D., Schilder, R. J., Cohn, D. E., Roman, L., Derynck, M. K., Ng, K.

Journal:

Journal of Clinical Oncology

Year:

2006

Language:

english

File:

PDF, 351 KB

english, 2006

79

β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers

Myers, Andrea, Barry, William T., Hirsch, Michelle S., Matulonis, Ursula, Lee, Larissa

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 142 KB

english, 2014

80

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Makhija, S., Amler, L. C., Glenn, D., Ueland, F. R., Gold, M. A., Dizon, D. S., Paton, V., Lin, C.-Y., Januario, T., Ng, K., Strauss, A., Kelsey, S., Sliwkowski, M. X., Matulonis, U.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 729 KB

english, 2010

81

Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

Cannistra, S. A., Matulonis, U. A., Penson, R. T., Hambleton, J., Dupont, J., Mackey, H., Douglas, J., Burger, R. A., Armstrong, D., Wenham, R., McGuire, W.

Journal:

Journal of Clinical Oncology

Year:

2007

Language:

english

File:

PDF, 114 KB

english, 2007

82

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Penson, Richard T., Moore, Kathleen M., Fleming, Gini F., Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A., Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C., Hozak,

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 637 KB

english, 2014

83

Analysis of intermediate clinical endpoints from a Phase II trial of olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC)

Matulonis, U.A., Harter, P., Gourley, C., Friedlander, M., Vergote, I.B., Rustin, G.J.S., Fielding, A., Spencer, S., Ho, T.W., Ledermann, J.A.

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 270 KB

english, 2014

84

Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer

Matulonis, U. A., Berlin, S., Ivy, P., Tyburski, K., Krasner, C., Zarwan, C., Berkenblit, A., Campos, S., Horowitz, N., Cannistra, S. A., Lee, H., Lee, J., Roche, M., Hill, M., Whalen, C., Sullivan, L

Journal:

Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 111 KB

english, 2009

85

POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: Implications for Lynch syndrome testing

Konstantinopoulos, Panagiotis A., Matulonis, Ursula A.

Journal:

Year:

2015

Language:

english

File:

PDF, 71 KB

english, 2015

86

10.1023/A:1008323200102

Burstein, H. J., Ramirez, M. J., Petros, W. P., Clarke, K. D., Warmuth, M. A., Marcom, P. K., Matulonis, U. A., Parker, L. M., Harris, L. N., Winer, E. P.

Journal:

Annals of Oncology

Year:

1999

Language:

english

File:

PDF, 305 KB

english, 1999

87

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

Matulonis, Ursula A., Oza, Amit M., Ho, Tony W., Ledermann, Jonathan A.

Journal:

Year:

2015

Language:

english

File:

PDF, 414 KB

english, 2015

88

Acupuncture for Chemotherapy-Induced Neutropenia in Patients with Gynecologic Malignancies: A Pilot Randomized, Sham-Controlled Clinical Trial

Lu, Weidong, Matulonis, Ursula A., Doherty-Gilman, Anne, Lee, Hang, Dean-Clower, Elizabeth, Rosulek, Andrew, Gibson, Carolyn, Goodman, Annekathryn, Davis, Roger B., Buring, Julie E., Wayne, Peter M.,

Journal:

Journal of Alternative and Complementary Medicine

Year:

2009

Language:

english

File:

PDF, 1.03 MB

english, 2009

89

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours

Penson, R T, Seiden, M V, Matulonis, U A, Appleman, L J, Fuller, A F, Goodman, A, Campos, S M, Clark, J W, Roche, M, Eder, J P

Journal:

British Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

90

Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma

Matulonis, Ursula, Vergote, Ignace, Backes, Floor, Martin, Lainie P., McMeekin, Scott, Birrer, Michael, Campana, Frank, Xu, Yi, Egile, Coumaran, Ghamande, Sharad

Journal:

Gynecologic Oncology

Year:

2015

Language:

english

File:

PDF, 523 KB

english, 2015

91

A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance

Ceccaldi, R., O'Connor, K. W., Mouw, K. W., Li, A. Y., Matulonis, U. A., D'Andrea, A. D., Konstantinopoulos, P. A.

Journal:

Cancer Research

Year:

2015

Language:

english

File:

PDF, 726 KB

english, 2015

92

Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Mullerian Tumors

Penson, R. T., Dizon, D. S., Cannistra, S. A., Roche, M. R., Krasner, C. N., Berlin, S. T., Horowitz, N. S., DiSilvestro, P. A., Matulonis, U. A., Lee, H., King, M. A., Campos, S. M.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 140 KB

english, 2010

93

CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations

Cramer, D. W., O'Rourke, D. J., Vitonis, A. F., Matulonis, U. A., DiJohnson, D. A., Sluss, P. M., Crum, C. P., Liu, B. C.- S.

Journal:

Clinical Chemistry

Year:

2010

Language:

english

File:

PDF, 471 KB

english, 2010

94

Rapid Development of Hypertension and Proteinuria with Cediranib, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor

Robinson, E. S., Matulonis, U. A., Ivy, P., Berlin, S. T., Tyburski, K., Penson, R. T., Humphreys, B. D.

Journal:

Clinical Journal of the American Society of Nephrology

Year:

2010

Language:

english

File:

PDF, 191 KB

english, 2010

95

Translational Impact of Nanoparticle-Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer

Pham, E., Birrer, M. J., Eliasof, S., Garmey, E. G., Lazarus, D., Lee, C. R., Man, S., Matulonis, U. A., Peters, C. G., Xu, P., Krasner, C., Kerbel, R. S.

Journal:

Clinical Cancer Research

Year:

2015

Language:

english

File:

PDF, 961 KB

english, 2015

96

Hopelessness and Complementary Therapy Use in Patients With Ovarian Cancer

Gross, Anne H., Cromwell, Jerry, Fonteyn, Marsha, Matulonis, Ursula A., Hayman, Laura L.

Journal:

Year:

2013

Language:

english

File:

PDF, 177 KB

english, 2013

97

Systemically and Topically Active Antinociceptive Neurotensin Compounds

Rossi, G. C., Matulonis, J. E., Richelson, E., Barbut, D., Pasternak, G. W.

Journal:

Journal of Pharmacology and Experimental Therapeutics

Year:

2010

Language:

english

File:

PDF, 561 KB

english, 2010

98

Place of Death: Correlations With Quality of Life of Patients With Cancer and Predictors of Bereaved Caregivers' Mental Health

Wright, A. A., Keating, N. L., Balboni, T. A., Matulonis, U. A., Block, S. D., Prigerson, H. G.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 129 KB

english, 2010

99

Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions

Pan, Y.-X., Xu, J., Xu, M., Rossi, G. C., Matulonis, J. E., Pasternak, G. W.

Journal:

Proceedings of the National Academy of Sciences

Year:

2009

Language:

english

File:

PDF, 854 KB

english, 2009

100

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

Callahan, M. J., Nagymanyoki, Z., Bonome, T., Johnson, M. E., Litkouhi, B., Sullivan, E. H., Hirsch, M. S., Matulonis, U. A., Liu, J., Birrer, M. J., Berkowitz, R. S., Mok, S. C.

Journal:

Clinical Cancer Research

Year:

2008

Language:

english

File:

PDF, 535 KB

english, 2008